Bristol-Myers Squibb Company
BMY.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$107.72B
Close$
$141.31
167.9% upside
Current Fair Value
167.9% upsideUndervalued by 167.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $107.72 Billion |
|---|---|
| Enterprise Value | $142.11 Billion |
| Dividend Yield | $2.02 (4.26%) |
| Earnings per Share | $3.47 |
| Beta | 0.24 |
| Outstanding Shares | 2,042,000,000 |
Return
| Return on Equity | 41.59% |
|---|---|
| Return on Assets | 10.59% |
| Return on Invested Capital | 17.75% |
Valuation & Multiples
| P/E Ratio | 13.02 |
|---|---|
| PEG | 8.5 |
| Price to Sales | 2.2 |
| Price to Book Ratio | 5.28 |
| Enterprise Value to Revenue | 2.89 |
| Enterprise Value to EBIT | 11.61 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 1.93 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$1.29
Average shareholder expectationRevenue Estimate
$9.49 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$1.40
Average shareholder expectationRevenue Estimate
$10.24 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bristol-Myers Squibb Co.
30,250 employees
CEO: Giovanni Caforio Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.